We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.07%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.62B
AUM Growth
+$83.9M
(+5.5%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
2,764
New
163
Increased
787
Reduced
971
Closed
110
Avg Time Held Equity + Options
2.4
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.4
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$20M |
| 2 |
ONEM
1Life Healthcare
ONEM
|
+$9.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.31M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$5.82M |
| 5 |
Okta
OKTA
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$26.7M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$10.8M |
| 3 |
CVB Financial
CVBF
|
+$10.7M |
| 4 |
Apple
AAPL
|
+$3.81M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$3.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.59% |
| 2 | Technology | 13.63% |
| 3 | Financials | 7.56% |
| 4 | Healthcare | 6.26% |
| 5 | Consumer Discretionary | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SYNH
2126
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4K | ﹤0.01% |
80
| – | – |
2017 Q4
11 quarters
|
|
|
UNVR
2127
DELISTED
Univar Solutions Inc.
UNVR
| $4K | ﹤0.01% |
260
-12
| -4% | -$212 |
2019 Q2
5 quarters
|
|
|
MAXR
2128
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $4K | ﹤0.01% |
170
| – | – |
2019 Q2
5 quarters
|
|
|
AUY
2129
DELISTED
Yamana Gold, Inc.
AUY
| $4K | ﹤0.01% |
+752
| New | +$4.51K |
2020 Q3
0 quarters
|
|
|
CHNG
2130
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $4K | ﹤0.01% |
251
| – | – |
2020 Q1
2 quarters
|
|
|
ZEAL
2131
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $4K | ﹤0.01% |
94
| – | – |
2020 Q1
2 quarters
|
|
|
ORPH
2132
DELISTED
Orphazyme A/S
ORPH
| $4K | ﹤0.01% |
+400
| New | +$4.01K |
2020 Q3
0 quarters
|
|
|
DRNA
2133
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4K | ﹤0.01% |
200
| – | – |
2020 Q2
1 quarter
|
|
|
WDR
2134
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4K | ﹤0.01% |
276
| – | – |
2020 Q2
1 quarter
|
|
|
HDS
2135
DELISTED
HD Supply Holdings, Inc.
HDS
| $4K | ﹤0.01% |
99
| – | – |
2019 Q3
4 quarters
|
|
|
SBNY
2136
DELISTED
Signature Bank
SBNY
| $4K | ﹤0.01% |
48
-55
| -53% | -$5.48K |
2019 Q4
3 quarters
|
|
|
BBL
2137
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $4K | ﹤0.01% |
+92
| New | +$4.11K |
2020 Q3
0 quarters
|
|
|
GSH
2138
DELISTED
Guangshen Railway Co. Ltd
GSH
| $4K | ﹤0.01% |
428
-388
| -48% | -$3.82K |
2019 Q2
5 quarters
|
|
2139
AllianceBernstein
AB
$3.21B
| $3K | ﹤0.01% |
109
+3
| +3% | +$84 |
2018 Q1
10 quarters
|
|
2140
iShares MSCI ACWI ex US ETF
ACWX
$17.5B
| $3K | ﹤0.01% |
62
+1
| +2% | +$46 |
2017 Q2
13 quarters
|
|
2141
American Eagle Outfitters
AEO
$3.05B
| $3K | ﹤0.01% |
192
| – | – |
2016 Q4
15 quarters
|
|
2142
AGCO
AGCO
$7.32B
| $3K | ﹤0.01% |
39
| – | – |
2019 Q2
5 quarters
|
|
2143
Assured Guaranty
AGO
$3.11B
| $3K | ﹤0.01% |
129
-122
| -49% | -$2.69K |
2016 Q4
15 quarters
|
|
2144
Antero Midstream
AM
$9.6B
| $3K | ﹤0.01% |
645
-488
| -43% | -$2.98K |
2019 Q2
5 quarters
|
|
2145
DELISTED
Apellis Pharmaceuticals
APLS
| $3K | ﹤0.01% |
110
-45
| -29% | -$1.34K |
2020 Q2
1 quarter
|
|
2146
Arrowhead Research
ARWR
$8.06B
| $3K | ﹤0.01% |
59
| – | – |
2020 Q1
2 quarters
|
|
2147
ATI
ATI
$25.7B
| $3K | ﹤0.01% |
297
-167
| -36% | -$1.54K |
2020 Q2
1 quarter
|
|
2148
Atara Biotherapeutics
ATRA
$95.2M
| $3K | ﹤0.01% |
8
| – | – |
2020 Q2
1 quarter
|
|
2149
Optimum Communications Inc
OPTU
$358M
| $3K | ﹤0.01% |
113
| – | – |
2020 Q1
2 quarters
|
|
2150
Brookfield
BN
$82.1B
| $3K | ﹤0.01% |
159
| – | – |
2016 Q4
15 quarters
|
|
Similar funds
Parallel Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Parallel Advisors held 2,764 positions worth $1.62B, up 5.5% from $1.53B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors's Q3 2020 filing shows 163 new, 787 increased, 971 reduced and 110 closed positions. Its largest new stake was 1Life Healthcare: 297,796 shares worth $8.45M. The largest sale was Microsoft, an estimated $26.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 54% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q3 2020 buy was 1Life Healthcare: 297,796 shares worth $8.45M.
- Parallel Advisors added most to iShares US Treasury Bond ETF in Q3 2020, an estimated $20M increase.
- Parallel Advisors's biggest Q3 2020 reduction was Microsoft, cutting an estimated $26.7M.
- Parallel Advisors fully exited Medallia, Inc. in Q3 2020, selling an estimated $851K.
- Parallel Advisors's ten largest holdings make up 35% of its $1.62B portfolio in Q3 2020.
- Parallel Advisors opened 163 new positions and closed 110 in Q3 2020.
- Parallel Advisors's portfolio value rose 5.5% quarter-over-quarter to $1.62B.
Based on Parallel Advisors's 13F filing for Q3 2020, filed 27 Oct 2020.